HK Stock Market Move | MARKETINGFORCE (02556) fell more than 10% with over one billion shares of restricted shares being unlocked. The company reported a loss of over 800 million yuan in the first half of the year.
Minsheng Holdings (02556) fell more than 10%, as of the time of publication, it fell 10.45% to HKD 99.4, with a turnover of HKD 13.2932 million.
MARKETINGFORCE (02556) fell over 10%, at the time of writing, down by 10.45% to HKD 99.4, with a turnover of HKD 1329.32 million.
On the news front, on November 16, MARKETINGFORCE saw the first issue of its shares. According to statistics, the company has over 100 million restricted shares released, accounting for 48.13% of the total share capital. Shareholders involved include Vickers Venture Partners, Gangxin Trading Co., Real Force Limited, Precious Sight Limited, and other major investors.
MARKETINGFORCE is known as China's largest marketing and sales software as a service (SaaS) solution provider, with a market share of 3.0% in 2023. In the first half of this year, the company achieved revenue of 739 million yuan, a year-on-year growth of 26.7%, with SaaS revenue of 400 million yuan, a year-on-year growth of 30.4%; shareholders' attributable loss was 820 million yuan, expanding by 1112.0% year-on-year.
Related Articles

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025